[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_95":96},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","j6w3gdt41fyueyry0710zfyix","revision",2,"title","Vicore Pharma Holding AB 提名委员会组成公布","originalTitle","6-K - Vicore Pharma Holding AB (0002124403) (Filer)","summary","Vicore Pharma Holding AB 于 11 月 3 日发布公告，公布 2027 年年度股东大会提名委员会的组成。大会定于 5 月 5 日举行；相关新闻稿作为附件列入 Form 6-K。","reason","source",{"_11":85,"_86":87,"_88":89,"_90":57,"_91":92,"_93":94},"links",{"_82":83,"_63":84},"publishedAt","2026-11-03T22:15:50.000Z","discoveredAt","2026-11-04T04:34:46.661Z","timelineAt","category","ai-products","tags",[81],"stockSymbols",[80],"score",13,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","fokbUXqWRFMo",{"_72":73,"_15":74},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","0dba0525-72d4-42c3-914f-1e2dbc7c898b","Vicore Pharma公布2027年股东大会提名委员会",{"_72":73,"_15":74},"zh","

UNITED STATES\n

SECURITIES AND EXCHANGE COMMISSION\n

Washington, D.C. 20549\n

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER\n

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934\n

For the month of November 2026\n

(Commission File No. 001-43312)

Vicore Pharma Holding AB\n

(Translation of registrant’s name into English)\n

Kornhamnstorg 53\n

SE-111 27 Stockholm,\n

Sweden\n

(Address of registrant’s principal executive office)\n

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7): ☐

Company Announcement \n

On November 3, 2026, Vicore Pharma Holding AB (the “Company”) issued a press release announcing the composition of the Company's nomination committee for the 2027 Annual General Meeting, which will take place on May 5, 2027. The press release is attached as Exhibit 99.1 and is incorporated by reference herein.

The information in the attached Exhibit 99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

\n\n \n \n \n \n \n \n\n

Exhibits

99.1	Press Release, dated November 3, 2026

SIGNATURES\n

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

\n\n \n \n \n \n \n \n \n \n\n

	Vicore Pharma Holding AB

	By:	/s/ Ahmed Mousa
	Name: Title:	Ahmed Mousa Chief Executive Officer

Date: November 3, 2026

","zhKind","complete","VCRE","公司与财报","aihot","/items/j6w3gdt41fyueyry0710zfyix","https://www.sec.gov/Archives/edgar/data/2124403/000143774926034704/0001437749-26-034704-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1794960000&sig=44baa70fbeef50e6","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1794960000&sig=a4957e0f65b84b31 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1794960000&sig=c50e8e83f0dcfb02 96w","changelogVersion","2026-10-01T08:00"]